Quantum computing is no longer an object of theoretical interest; it has become an object of investment, and the startups in this field have topped 2.8 billion dollars in the first week of 2026, which is more than the entire funding of 2025. This influx of capital marks a turning point: quantum is leaving the research laboratories and is entering the practical world, and VC funding of early stage startups is changing to suit these long gestation, capital-intensive opportunities.
The discovery that has attracted investor attention is a photonic quantum computing company that has exhibited fault tolerance with only 100 physical qubits an astounding feat that would shrink time scales by decades. Their system uses room temperature instead of near-absolute-zero cooling, which has been the bane of the industry, so their system addresses the issue of scalability. Applications The consequences are spread into cryptography, drug discovery, financial modeling and materials science.
This is being spearheaded by the corporate venture arms. The AWS of Amazon, Alphabet of Google, and JPMorgan Chase have individually invested about 1.2 billion in quantum startups, and they consider the technology as indispensable to their competitive niche. This company accreditation has dragged conventional venture capital back in the arena. Some of the funds that had not been investing in deep tech are now establishing quantum-specific investment vehicles that have longer time frames and larger pockets.
The Deep Tech New Funding Stack.
The process of Raising Capital to Startups in quantum computing must take a completely different approach than SaaS or consumer applications. The normal 18 months period between landing and takeoff is ridiculously insufficient. Quantum hardware firms require 3-5 years to realize technical milestones that open the value.
The new normal is milestone-based tranching. Instead of getting a single shot of $50 million, founders have commitments of $150 million that is spread across three technical gates: qubit stability, error correction demonstration, and commercial pilot. This minimizes the dilution and provides capital to long R&D cycles.
Anchors of cap table in the form of government grants. Non-diluteive capital being offered by the U.S. CHIPS Act, EU Quantum Flagship and other programs in the world is capable of financing 30-40 per cent of the initial development. These grants are used by smart founders as validation cues, where they seek to raise funds at high valuations.
Defensible strategic corporate partnerships. Quantum companies establish exclusivity by partnering with end-users in the creation of applications as opposed to software startups that establish moats based on network effects. The existence of a quantum chemistry startup with three of five largest pharmaceutical companies is an effective way to prevent competitors gaining access to the customer relationships.
Hook Title: Quantum Winter Is Coming -Or Is It?
The viral fight dividing the venture industry: are we entering a quantum winter like AI in 2018? The ten years taken between technical demonstration and commercial success is mentioned by skeptics. Optimists respond by indicating that hybrid classical-quantum devices are already earning money in optimization problems, and full-scale fault-tolerant devices will be available in 3-5 years, not decades.
Such words as quantum advantage are the most searched expressions in VC pitch decks. It is the point of inflection at which quantum computers will readily outperform classical supercomputers at tackling problems of commercial interest. We can see the beginning of quantum advantage in small areas set to benefit asset managers: portfolio optimization, drug discovery: molecular simulation, logistics: route optimization.
Virga is not the most viral startup in the space which is not building quantum computers. They are developing the Windows on quantum- middleware which hides hardware complexity, enabling quantum algorithm writers not to know physics. It has raised $180 million in Series A funding, the biggest early-stage round in quantum history, due to the fact that this platform play overcomes the bottleneck of talent. There are not enough PhDs in quantum, globally under 1,000, so access that is democratized by abstraction layer would be more useful than the device.
Due Diligence Evolution
Quantum startups demand technical due diligence skills out of capability of most venture capital firms. The solution? Physicist, engineer, and traditional VC hybrid investment committees. Other companies are going to the extent of acquiring quantum consultancies to generate in-house knowledge.
Financial metrics have been substituted with technical milestones as a source of valuation. A start-up that has a qubit fidelity of 99.9 can increase its valuation by 5x overnight, with zero revenue. This gives it distinctive fundraising timelines strategies: founders race to milestones and run out of capital before they can raise, and timing raises to run out of capital as soon as you break an announcement.
Expert Advice of Evolve Venture Capital.
Since quantum opportunities are being restructured in venture capital investing in early stage startups, our framework focuses on:
Founder-market fit as opposed to founder-background fit. The most talented quantum founders do not necessarily have PhDs and Nature papers. They are repeat entrepreneurs who are building teams of the best technical minds, and never give up on commercial applications. Seek founders who address customer ROI, not qubit coherence.
Application-layer timing. Although hardware takes the headlines, applications can be the most investable point. Quantum algorithm startups in drug discovery, materials science or cryptography can have faster revenue generation and less capital requirement than hardware plays. They also experience less technological risk through hardware enhancements offered by a variety of vendors.
Capital intensity as strength rather than weakness. Quantum startups are in the range of 100M+ necessary to become commercially viable. This spawns natural barriers to entry and winner-take-most. Underfunding is death in deep tech. We would prefer to have a single leader that is fully funded than three followers with limited capital.
Quantum revolution is not going to occur overnight but it will occur at a faster rate than most of us expect. In the case of founders, this refers to a 7-10 year trip as you establish interim revenue sources to justify your technology. To investors, it implies building the portfolios, which are capable of absorbing the technical risk and which are able to recover the asymmetric upside. We have invested 15% of our recent fund in quantum and adjacency deep tech at Evolve Venture Capital, and the reserves are designed to fund companies across various technical milestones. Individuals who mix patient capital and impatient capital will be the winners in this space.
Contact Information:
Phone: +65 8181 4097
© 2025 Crivva - Hosted by Airy Hosting Managed Website Hosting.
